Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance.
暂无分享,去创建一个
Zhe-Sheng Chen | L. Fu | A. Tiwari | E. Hopper-Borge | T. Shen | Y. Kuang | K. Sodani | Xiang Chen | J. W. Lee
暂无分享,去创建一个
Zhe-Sheng Chen | L. Fu | A. Tiwari | E. Hopper-Borge | T. Shen | Y. Kuang | K. Sodani | Xiang Chen | J. W. Lee